SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

ProNAi Therapeutics Inc (DNAI)

DNAI RSS Feed
Add DNAI Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 12/6/2016 1:24:59 PM - Followers: 25 - Board type: Free - Posts Today: 0



A clinical-stage oncology company pioneering a novel class of therapeutics based on our proprietary DNA interference (DNAi®) technology platform.

Their vision is to be the leader in developing and commercializing a portfolio of DNAi-based therapies to deliver extraordinary therapeutic outcomes that dramatically change patients’ lives.

Their lead DNAi product candidate, PNT2258, targets BCL2, a widely overexpressed oncogene that is an important gatekeeper of the programmed cell death process known as apoptosis and has been linked to many forms of cancer. They believe the preliminary evidence of efficacy, safety and tolerability observed to date suggest that PNT2258 has the potential to change treatment paradigms across a wide range of oncology indications. They recently initiated Wolverine, a Phase 2 trial for the treatment of third-line relapsed or refractory DLBCL, and by mid-2015, we plan to initiate Brighton a Phase 2 trial for the treatment of Richter’s.

NEWS RELEASE

ProNAi to Present at Jefferies Autumn 2015 Global Healthcare Conference in London

VANCOUVER, Nov. 11, 2015 /CNW/ - ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company at the Jefferies Autumn 2015 Global Healthcare Conference in London.

The presentation is scheduled for 4:40 pm (GMT) on Thursday, November 19th. A live webcast of the presentation will be accessible through the ProNAi website at www.pronai.com.  An archived replay of the presentation will also be available.

About ProNAi Therapeutics
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform for patients with cancer and hematological diseases. ProNAi's lead DNAi product candidate, PNT2258, is designed to treat cancers that overexpress BCL2, an important and validated oncogene known to be dysregulated in many types of cancer. ProNAi is pursuing a multi-faceted clinical development strategy designed to efficiently achieve regulatory approval and maximize the commercial opportunity of PNT2258. ProNAi is actively enrolling patients in "Wolverine", a Phase 2 trial evaluating PNT2258 for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and in "Brighton", a Phase 2 trial evaluating PNT2258 for the treatment of Richter's transformation. For more information, please visitwww.pronai.com.

Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding ProNAi's anticipated clinical development activities, including the design, timing and outcome of such activities. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are subject to risks and uncertainties, including, among others, the risk that ProNAi may be unable to successfully develop and commercialize PNT2258 or any other future product candidates, PNT2258 may fail to demonstrate safety and efficacy or may not otherwise produce positive results, ProNAi may experience delays in clinical trials, including due to difficulties enrolling patients, ProNAi's third-party manufacturers may cause its supply of materials to become limited or interrupted or fail to be of satisfactory quantity or quality,
ProNAi's cash resources may be insufficient to fund its current operating plans and it may be unable to raise additional capital when needed, ProNAi may be unable to obtain and enforce intellectual property protection for its technologies and product candidates and the other factors described under the heading "Risk Factors" set forth in ProNAi's filings with the Securities and Exchange Commission from time to time, including the Company's reports filed with the Securities and Exchange Commission. ProNAi undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DNAI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
DNAI News: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ProNAi Therapeutics, Inc. - DNAI 11/23/2016 12:47:00 PM
DNAI News: Confidential Treatment Order (ct Order) 11/18/2016 11:27:47 AM
DNAI News: SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ProNAi Therapeutics, Inc. (D... 11/17/2016 02:18:00 PM
DNAI News: Harwood Feffer LLP Announces Investigation of ProNAi Therapeutics, Inc. 11/15/2016 03:50:00 PM
DNAI News: Robbins Arroyo LLP: ProNAi Therapeutics, Inc. (DNAI) Misled Shareholders According to a Recently Filed Class Action 11/15/2016 01:40:00 PM
PostSubject
#301   Here we go! harmsen 12/06/16 01:24:59 PM
#300   DNAI Trading Way to Cheap These Sellers are Stockexpertpro 12/06/16 10:24:10 AM
#299   Added for quick play! DEADSKY 12/02/16 11:56:26 AM
#298   Gonna open +60% one of these days, easy Giovinco 11/03/16 12:09:55 PM
#297   Still just watching it,looking for bottom. sick nam vet 11/02/16 04:17:01 PM
#296   Been reading the latest SEC Filings seen the Stockexpertpro 11/02/16 04:00:25 PM
#295   GAME OVER BAGHOLDERS YOU LOSE SELL SELL SELL Stockexpertpro 11/02/16 03:49:42 PM
#294   THis one just keeps getting worst and worst,on sick nam vet 10/28/16 12:01:56 PM
#293   Man this used to be a money maker,hope sick nam vet 10/25/16 12:37:36 PM
#292   Another New low $1.62 just hit! DNAI is Value_Investor 10/25/16 12:02:32 PM
#291   Back on my watch list. sick nam vet 10/25/16 11:37:19 AM
#290   New low of year today. sick nam vet 10/25/16 11:36:35 AM
#289   yes but now it's so extreme compared to Giovinco 10/24/16 12:51:30 PM
#288   LOL this pos is being pumped every where spottrader 10/24/16 12:29:52 PM
#287   More than $4 Cash Easy huge gain long Giovinco 10/24/16 11:48:03 AM
#286   Another New 52-week low $1.63 was created today! Value_Investor 10/24/16 10:33:34 AM
#285   The pos scam closed at daily low $1.72 Value_Investor 10/21/16 04:17:13 PM
#284   Another new low $1.71 was created yesterday! This Value_Investor 10/21/16 11:36:10 AM
#283   The New 52-week low $1.73 was created this Value_Investor 10/18/16 04:23:29 PM
#282   DNAI hit $1.78 Twice this week! We should Value_Investor 10/14/16 04:56:19 PM
#281   LOL, DNAI hit the new low $1.78 today Value_Investor 10/11/16 03:11:46 PM
#280   How could a Debt-Free and High BV ($4.13) Value_Investor 10/09/16 10:19:31 PM
#279   LOL, this Nasdaq Bio-Tech pos scam (DNAI) declined Value_Investor 10/07/16 04:57:31 PM
#278   Yes. Serious manipulations everyday with DNAI! Where come Value_Investor 10/06/16 10:40:05 PM
#277   Nice 5.03% bouncing so far from the New Value_Investor 10/05/16 12:12:34 PM
#276   I hope it moves this time Sone 10/05/16 08:12:40 AM
#275   Good news kicked in for DNAI at 5:10 Value_Investor 10/04/16 11:46:29 PM
#274   DNAI hit the new low $1.79 today! Only Value_Investor 10/04/16 04:55:04 PM
#273   Why the so-called "good news" brought DNAI down Value_Investor 10/03/16 12:14:04 PM
#271   Another bad news kicked in yesterday in the Value_Investor 10/01/16 03:00:11 PM
#270   LOL, after the so-called "good news" DNAI declined Value_Investor 09/30/16 03:02:11 PM
#269   ProNAi nabs rights to small molecule cancer candidate news sniffer outer 09/27/16 10:48:43 AM
#268   ProNAi will host an Analyst and Investor conference RNsidersbuying 09/27/16 09:20:23 AM
#267   Wohoo news Sone 09/27/16 08:42:43 AM
#265   Understood all the investor's frustrations with this pos Value_Investor 09/16/16 04:53:26 PM
#264   This maybe only a back up plan, but Sunofwolf 09/13/16 08:11:07 AM
#263   If the crap CEO didn't file that bullshit Value_Investor 09/12/16 11:28:47 PM
#262   I have given up on this stock-it just Sunofwolf 09/12/16 06:27:22 PM
#261   This would still have over two dollars in Sunofwolf 09/10/16 07:19:07 PM
#260   Not sure if your right about what the Sunofwolf 09/10/16 02:55:49 PM
#259   Very bad fundamental news for DNAI! Giant OS Value_Investor 09/09/16 03:37:32 PM
#258   Yup, no reason to be down here... PROPHETABLE 09/08/16 03:56:44 PM
#257   DNAI 130 Million in Cash no debt Trading Stockexpertpro 09/08/16 03:54:51 PM
#256   A little bit at a time-We head to $4.50! Sunofwolf 09/07/16 05:55:00 PM
#255   Book value has it at over $4! Sunofwolf 09/06/16 07:03:04 PM
#254   Been movin up all day1 Sunofwolf 09/06/16 03:14:08 PM
#253   I would think News is coming this week! Sunofwolf 09/06/16 09:07:18 AM
#252   the ceo will start batting this month! Sunofwolf 09/02/16 11:43:19 AM
#251   Well maybe we get some News next week! Sunofwolf 09/01/16 04:12:43 PM
#250   I think you are right on that. JeffAdams05 08/31/16 03:25:26 PM
PostSubject